Experienced in Fibrosarcoma

Dr. Joseph M. Caster

Radiation Oncology
Jefferson University Physicians
111 S 11th St, 
Philadelphia, PA 
Accepting New Patients
Experienced in Fibrosarcoma
Jefferson University Physicians
111 S 11th St, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joseph Caster is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Caster is rated as an Experienced provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Endometrial Cancer, and Endometrial Stromal Sarcoma. Dr. Caster is currently accepting new patients.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in IA
Hospital Affiliations
University Of Iowa Hospital & Clinics
Ottumwa Regional Health Center
Thomas Jefferson University Hospital
Southeast Iowa Regional Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medical Associates
  • MEDICARE MAPD
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 8 Less Insurance Carriers -

Locations

JEFFERSON UNIVERSITY PHYSICIANS
111 S 11th St, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
A Phase 1b/2 Trial of Preoperative Niraparib, Dostarlimab, and Hypofractionated Radiotherapy for the Treatment of Locally-advanced Rectal Cancers.
A Phase 1b/2 Trial of Preoperative Niraparib, Dostarlimab, and Hypofractionated Radiotherapy for the Treatment of Locally-advanced Rectal Cancers.
Enrollment Status: Terminated
Publish Date: June 29, 2025
Intervention Type: Drug, Radiation
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 1/Phase 2
GRECO-2: A Randomized, Phase 2b Study of GC4711 in Combination With Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer
GRECO-2: A Randomized, Phase 2b Study of GC4711 in Combination With Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer
Enrollment Status: Terminated
Publish Date: May 21, 2024
Intervention Type: Drug
Study Drug: Drug GC4711
Study Phase: Phase 2
View 2 Less Clinical Trials

48 Total Publications

Author Correction: Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.
Author Correction: Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.
Journal: Nature biomedical engineering
Published: April 09, 2025
Similar Doctors
Advanced in Fibrosarcoma
Dr. William P. Levin
Radiation Oncology
Advanced in Fibrosarcoma
Dr. William P. Levin
Radiation Oncology

Penn Radiation Oncology Perelman-Concourse Level

3400 Civic Center Boulevard, Concourse Level, 
Philadelphia, PA 
 (1.8 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Levin is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Levin is rated as a Distinguished provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Thymic Epithelial Tumor, and Small Cell Lung Cancer (SCLC). Dr. Levin is currently accepting new patients.

Advanced in Fibrosarcoma
Dr. Abigail T. Berman
Radiation Oncology
Advanced in Fibrosarcoma
Dr. Abigail T. Berman
Radiation Oncology

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (3.9 miles away)
215-707-3008
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Abigail Berman is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Berman is rated as a Distinguished provider by MediFind in the treatment of Fibrosarcoma. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Small Cell Lung Cancer (SCLC). Dr. Berman is currently accepting new patients.

Advanced in Fibrosarcoma
Dr. Keith Cengel
Radiation Oncology
Advanced in Fibrosarcoma
Dr. Keith Cengel
Radiation Oncology

Abramson Cancer Center Penn Presbyterian

51 N. 39th Street, Pavilion For Advanced Care, First Floor, 
Philadelphia, PA 
 (2.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Keith Cengel is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Cengel is rated as an Elite provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Mesothelioma, Lung Cancer, Metastatic Pleural Tumor, Small Cell Lung Cancer (SCLC), and Liver Embolization. Dr. Cengel is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Caster's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 54 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile